125 related articles for article (PubMed ID: 38663712)
1. Gyrate atrophy of the choroid and retina: Update on diagnosis and treatment.
Merino Diez MT; Soria Prada C; Zamorano Aleixandre M; Gonzalez-Lopez JJ
Arch Soc Esp Oftalmol (Engl Ed); 2024 Apr; ():. PubMed ID: 38663712
[TBL] [Abstract][Full Text] [Related]
2. Gyrate Atrophy of the Choroid and Retina: A Review.
Elnahry AG; Elnahry GA
Eur J Ophthalmol; 2022 May; 32(3):1314-1323. PubMed ID: 34894815
[TBL] [Abstract][Full Text] [Related]
3. A review of treatment modalities in gyrate atrophy of the choroid and retina (GACR).
Balfoort BM; Buijs MJN; Ten Asbroek ALMA; Bergen AAB; Boon CJF; Ferreira EA; Houtkooper RH; Wagenmakers MAEM; Wanders RJA; Waterham HR; Timmer C; van Karnebeek CD; Brands MM
Mol Genet Metab; 2021; 134(1-2):96-116. PubMed ID: 34340878
[TBL] [Abstract][Full Text] [Related]
4. Gyrate atrophy of the choroid and retina with hyperornithinaemia, cystinuria and lysinuria.
Khan MY; Ibraheim AS; Firoozmand S
Eye (Lond); 1994; 8 ( Pt 3)():284-7. PubMed ID: 7958031
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of a combination of next-generation sequencing, chorioretinal imaging and metabolic analysis: lessons from a consanguineous Chinese family with gyrate atrophy of the choroid and retina stemming from a novel OAT variant.
Huang J; Fu J; Fu S; Yang L; Nie K; Duan C; Cheng J; Li Y; Lv H; Chen R; Liu L; Fu J
Br J Ophthalmol; 2019 Mar; 103(3):428-435. PubMed ID: 30366948
[TBL] [Abstract][Full Text] [Related]
6. Low-protein diet and progression of retinal degeneration in gyrate atrophy of the choroid and retina: a twenty-six-year follow-up.
Santinelli R; Costagliola C; Tolone C; D'Aloia A; D'Avanzo A; Prisco F; Perrone L; del Giudice EM
J Inherit Metab Dis; 2004; 27(2):187-96. PubMed ID: 15159649
[TBL] [Abstract][Full Text] [Related]
7. Foveoschisis associated with gyrate atrophy in ornithine aminotransferase deficiency: A case report.
Berhuni M; Tıskaoğlu NS
Photodiagnosis Photodyn Ther; 2023 Jun; 42():103618. PubMed ID: 37209764
[TBL] [Abstract][Full Text] [Related]
8. Clinical, biochemical and molecular analysis in a cohort of individuals with gyrate atrophy.
Palmer E; Stepien KM; Campbell C; Barton S; Iosifidis C; Ghosh A; Broomfield A; Woodall A; Wilcox G; Sergouniotis PI; Black GC
Orphanet J Rare Dis; 2023 Sep; 18(1):265. PubMed ID: 37667371
[TBL] [Abstract][Full Text] [Related]
9. Correction of ornithine accumulation prevents retinal degeneration in a mouse model of gyrate atrophy of the choroid and retina.
Wang T; Steel G; Milam AH; Valle D
Proc Natl Acad Sci U S A; 2000 Feb; 97(3):1224-9. PubMed ID: 10655512
[TBL] [Abstract][Full Text] [Related]
10. First report of c.425-1G>A mutation in ornithine aminotransferase gene causing gyrate atrophy of the choroid and retina with hyperornithinemia.
Jalali H; Najafi M; Khoshaeen A; Mahdavi MR; Mahdavi M
Eur J Ophthalmol; 2021 Sep; 31(5):NP23-NP26. PubMed ID: 32418451
[TBL] [Abstract][Full Text] [Related]
11. A neonate with ornithine aminotransferase deficiency; insights on the hyperammonemia-associated biochemical phenotype of gyrate atrophy.
Kaczmarczyk A; Baker M; Diddle J; Yuzyuk T; Valle D; Lindstrom K
Mol Genet Metab Rep; 2022 Jun; 31():100857. PubMed ID: 35782604
[TBL] [Abstract][Full Text] [Related]
12. Liver-directed gene therapy for ornithine aminotransferase deficiency.
Boffa I; Polishchuk E; De Stefano L; Dell'Aquila F; Nusco E; Marrocco E; Audano M; Pedretti S; Caterino M; Bellezza I; Ruoppolo M; Mitro N; Cellini B; Auricchio A; Brunetti-Pierri N
EMBO Mol Med; 2023 Apr; 15(4):e17033. PubMed ID: 36647689
[TBL] [Abstract][Full Text] [Related]
13. Gyrate atrophy of the choroid and retina diagnosed by ornithine-δ-aminotransferase gene analysis: a case report.
Kim SJ; Lim DH; Kim JH; Kang SW
Korean J Ophthalmol; 2013 Oct; 27(5):388-91. PubMed ID: 24082780
[TBL] [Abstract][Full Text] [Related]
14. A Case of Foveoschisis Associated with Ornithine Aminotransferase Deficiency and Gyrate Atrophy.
Ozcaliskan S; Balci S; Artunay O
J Coll Physicians Surg Pak; 2021 Nov; 31(11):1354-1356. PubMed ID: 34689497
[TBL] [Abstract][Full Text] [Related]
15. OAT mutations and clinical features in two Japanese brothers with gyrate atrophy of the choroid and retina.
Katagiri S; Gekka T; Hayashi T; Ida H; Ohashi T; Eto Y; Tsuneoka H
Doc Ophthalmol; 2014 Apr; 128(2):137-48. PubMed ID: 24429551
[TBL] [Abstract][Full Text] [Related]
16. A Novel Ornithine Aminotransferase Splice Site Mutation Causes Vitamin B6-Responsive Gyrate Atrophy.
Molaei Ramshe S; Zardadi S; Alehabib E; Nourinia R; Jamshidi J; Soosanabadi M; Darvish H
J Ophthalmic Vis Res; 2024; 19(1):118-132. PubMed ID: 38638626
[TBL] [Abstract][Full Text] [Related]
17. Bevacizumab for the treatment of intraretinal cystic spaces in a patient with gyrate atrophy of the choroid and retina.
Elnahry AG; Hassan FK; Abdel-Kader AA
Ophthalmic Genet; 2018 Dec; 39(6):759-762. PubMed ID: 30335551
[TBL] [Abstract][Full Text] [Related]
18. Gyrate atrophy of the choroid and retina with hyper-ornithinemia responsive to vitamin B6: a case report.
Javadzadeh A; Gharabaghi D
J Med Case Rep; 2007 Jun; 1():27. PubMed ID: 17565677
[TBL] [Abstract][Full Text] [Related]
19. Carbonic Anhydrase Inhibitor with Topical NSAID Therapy to Manage Cystoid Macular Edema in a Case of Gyrate Atrophy.
Piozzi E; Alessi S; Santambrogio S; Cillino G; Mazza M; Iggui A; Cillino S
Eur J Ophthalmol; 2017 Nov; 27(6):e179-e183. PubMed ID: 28708224
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
